✦ LIBER ✦

TCT-35: Safety and Effectiveness Of Sirolimus-Eluting and Zotarolimus-Eluting Stents in Diabetic and Non-Diabetic Patients in Western Denmark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EVEROLIMUS-ELUTING VERSUS SIROLIMUS-ELUT

✍ Park, Duk-Woo; Lee, chang hoon; Park, Gyung-Min; Kim, Yong-Giun; Hwang, Ki Won; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 117 KB

TCT-194 5-Year Outcome Of Zotarolimus-El

✍ Maeng, Michael; Christiansen, Evald H.; Jensen, Lisette Okkels; Kaltoft, Anne; M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 116 KB

AS-229 Everolimus-Eluting Versus Sirolim

✍ Duk-Woo Park; Chang Hoo Lee; Gyung-Min Park; Ki Won Hwang; Jung-Min Ahn; Hae Geu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 94 KB

TCT-337 Clinical Outcome of Diabetic and

✍ Kenneth Tandjung; Hanim Sen; Mounir Basalus; K. Gert van Houwelingen; Marije Löw 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Sirolimus-eluting versus paclitaxel-elut

✍ Kufner, Sebastian; Byrne, Robert A.; de Waha, Antoinette; Schulz, Stefanie; Jone 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 363 KB

TCT-374: Angiographic Late Lumen Loss an

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 243 KB